Key statistics
On Monday, Rigel Pharmaceuticals Inc (RI2:FRA) closed at 28.00, 97.18% above the 52 week low of 14.20 set on Apr 16, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 28.40 |
|---|---|
| High | 28.40 |
| Low | 28.00 |
| Bid | 28.20 |
| Offer | 29.40 |
| Previous close | 28.20 |
| Average volume | 112.40 |
|---|---|
| Shares outstanding | 18.15m |
| Free float | 17.68m |
| P/E (TTM) | 5.54 |
| Market cap | 619.87m USD |
| EPS (TTM) | 6.17 USD |
Data delayed at least 15 minutes, as of Feb 09 2026 14:49 GMT.
More ▼
Press releases
- Rigel Appoints Michael P. Miller to the Board of Directors
- Rigel Provides Business Update and 2026 Outlook
- Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
- Rigel to Present at the 44th Annual J.P. Morgan Healthcare Conference
- Rigel Presents Updated Data from the Ongoing Phase 1b Study Evaluating R289 in Patients with Lower-Risk MDS at the 67th ASH Annual Meeting and Exposition
- Rigel to Present at the Piper Sandler 37th Annual Healthcare Conference
- Rigel Announces Publication of Final 5-year Data on REZLIDHIA® (olutasidenib) in Patients with R/R mIDH1 AML in the Journal of Hematology & Oncology
- Rigel to Present at the Jefferies Global Healthcare Conference in London
More ▼
